Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

Seven-year follow-up data on over 1400 patients show radium-223's long-term safety, with a low 2% secondary malignancy rate, reflecting real-world use.

Adding niraparib to AAP and ADT improved rPFS in mCSPC patients with HRR mutations in the phase 3 AMPLITUDE trial.

This article examines how physical activity and exercise influence cancer prevention, mitigate treatment-related side effects, enhance quality of life and impact overall mortality in oncology patients ...

Study results highlight the need to improve adverse event cost quantification in oncology cost-effectiveness analyses, researchers say.

A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway ...

Aussie men are being encouraged to step up and put their health first, by learning the lifesaving signs of stroke and then ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking news on SWAC athletic directors' legal ...

Rhod Gilbert and the Giant Grapefruit at Eventim Apollo: 'rage, heart and lashings of dark humour' - 5/5 The Welsh comedian’s ...

Air Force veteran Andrin Jones, of Matteson, was diagnosed with prostate cancer three years ago but survived because it was ...

Acupuncture produced significantly greater reductions in nocturia episodes and IPSS scores in survivors of prostate cancer ...